Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists

Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists

US Patent 6458817 · Granted Oct 1, 2002

Estimated economic value: $95,447,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

1-(arylsulfonyl)-4-(piperazin-1-yl)-1H-benzimidazoles as 5-hydroxytryptamine-6 l2011
Aminoazacyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands2011
Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-s2010
Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-s2010
Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimu2010
Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimu2010
Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stim2010
Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulat2010
Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulat2010
3-aryl-4-hydroxyfuranone compounds and the human and animal health use thereof2010
3-aryl-4-hydroxyfuranone compounds and the human and animal health use thereof2010
Dihydrospiro[dibenzo[a,d][7]annulene-5,4′-imidazol] compounds for the inhibition2009